Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Lupin Expands Coral Springs, Florida, Operations

12/29/2025
Global pharmaceutical company Lupin plans to expand its operations in Coral Springs, Florida. The $250 million project is expected to create 200 jobs by 2030 in Broward County.

The investment will include the construction of a new 70,000-square-foot manufacturing facility which will anchor U.S. production of critical respiratory therapies.

“The expansion of Lupin’s footprint in Coral Springs is a core part of our growth strategy. This new?state-of-the-art?facility will build on our existing presence in Florida, which is home to Lupin’s headquarters and our Advanced Inhalation Research Center. This investment?demonstrates?Lupin’s commitment to innovation,?quality?and supply chain reliability — and our ability to partner with Florida’s leaders to strengthen America’s medicine security by growing our capacity to produce affordable treatments for patients.?We?are grateful?to Florida’s leadership?for their?partnership in making this?possible,” said Christoph Funke, Chief Technical Operations Officer, Lupin.

To support the project Lupin will receive tax credits and incentives from the state of Florida.

“On behalf of FloridaCommerce, I’m excited to welcome Lupin’s expansion in Coral Springs and the high-impact investment it brings to our state,” noted Florida Secretary of Commerce J. Alex Kelly.

Lupin Ltd. specializes in generics and biosimilars, developing and manufacturing medicines in areas like respiratory, cardiovascular, anti-infectives, and CNS, with a strong focus on R&D, including complex generics, APIs, and branded products.

Exclusive Research